Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 57

1.

Toward a pre-clinical irradiator using clinical infrastructure.

Parsons D, Church C, Syme A.

Phys Med. 2019 Feb;58:21-31. doi: 10.1016/j.ejmp.2019.01.006. Epub 2019 Jan 18.

PMID:
30824146
2.

Capacity To Utilize Raffinose Dictates Pneumococcal Disease Phenotype.

Minhas V, Harvey RM, McAllister LJ, Seemann T, Syme AE, Baines SL, Paton JC, Trappetti C.

MBio. 2019 Jan 15;10(1). pii: e02596-18. doi: 10.1128/mBio.02596-18.

3.

Intra-arc binary collimation algorithm for the optimization of stereotactic radiotherapy treatment of multiple metastases with multiple prescriptions.

MacDonald RL, Thomas CG, Ward L, Syme A.

Med Phys. 2018 Dec;45(12):5597-5607. doi: 10.1002/mp.13224. Epub 2018 Oct 24.

PMID:
30288758
4.

Absorbed dose kernel and self-shielding calculations for a novel radiopaque glass microsphere for transarterial radioembolization.

Church C, Mawko G, Archambault JP, Lewandowski R, Liu D, Kehoe S, Boyd D, Abraham R, Syme A.

Med Phys. 2018 Feb;45(2):934-942. doi: 10.1002/mp.12717. Epub 2017 Dec 25.

PMID:
29206288
5.

Dynamic collimator trajectory algorithm for multiple metastases dynamic conformal arc treatment planning.

MacDonald RL, Thomas CG, Syme A.

Med Phys. 2018 Jan;45(1):5-17. doi: 10.1002/mp.12648. Epub 2017 Nov 27.

PMID:
29094419
6.

Adherence to a lifestyle program for youth with type 2 diabetes and its association with treatment outcome in the TODAY clinical trial.

Berkowitz RI, Marcus MD, Anderson BJ, Delahanty L, Grover N, Kriska A, Laffel L, Syme A, Venditti E, Van Buren DJ, Wilfley DE, Yasuda P, Hirst K; TODAY Study Group.

Pediatr Diabetes. 2018 Mar;19(2):191-198. doi: 10.1111/pedi.12555. Epub 2017 Jun 30.

7.

CTCF facilitates DNA double-strand break repair by enhancing homologous recombination repair.

Hilmi K, Jangal M, Marques M, Zhao T, Saad A, Zhang C, Luo VM, Syme A, Rejon C, Yu Z, Krum A, Fabian MR, Richard S, Alaoui-Jamali M, Orthwein A, McCaffrey L, Witcher M.

Sci Adv. 2017 May 24;3(5):e1601898. doi: 10.1126/sciadv.1601898. eCollection 2017 May.

8.

Structure to utilize interventionists' implementation experiences of a family-based behavioral weight management program to enhance the dissemination of the standardized intervention: The TODAY study.

Chadwick JQ, Van Buren DJ, Morales E, Timpson A, Abrams EL, Syme A, Preske J, Mireles G, Anderson B, Grover N, Laffel L.

Clin Trials. 2017 Aug;14(4):406-412. doi: 10.1177/1740774517707727. Epub 2017 May 9.

9.

Single-Dose Radiation-Induced Oral Mucositis Mouse Model.

Maria OM, Syme A, Eliopoulos N, Muanza T.

Front Oncol. 2016 Jun 27;6:154. doi: 10.3389/fonc.2016.00154. eCollection 2016.

10.

Adipose mesenchymal stromal cells minimize and repair radiation-induced oral mucositis.

Maria OM, Shalaby M, Syme A, Eliopoulos N, Muanza T.

Cytotherapy. 2016 Sep;18(9):1129-45. doi: 10.1016/j.jcyt.2016.06.008. Epub 2016 Jul 14.

PMID:
27424150
11.

Adipose mesenchymal stromal cells response to ionizing radiation.

Maria OM, Kumala S, Heravi M, Syme A, Eliopoulos N, Muanza T.

Cytotherapy. 2016 Mar;18(3):384-401. doi: 10.1016/j.jcyt.2015.12.001. Epub 2016 Jan 15.

PMID:
26780866
12.

Phosphorylation of eIF2╬▒ Is a Translational Control Mechanism Regulating Muscle Stem Cell Quiescence and Self-Renewal.

Zismanov V, Chichkov V, Colangelo V, Jamet S, Wang S, Syme A, Koromilas AE, Crist C.

Cell Stem Cell. 2016 Jan 7;18(1):79-90. doi: 10.1016/j.stem.2015.09.020. Epub 2015 Nov 5.

13.

Prospective phase II study of tomotherapy based chemoradiation treatment for locally advanced anal cancer.

Joseph K, Nijjar Y, Warkentin H, Schiller D, Tankel K, Usmani N, Severin D, Ghosh S, Syme A, Nijjar T, Mulder K, Doll C, Wong C, Field C.

Radiother Oncol. 2015 Nov;117(2):234-9. doi: 10.1016/j.radonc.2015.08.008. Epub 2015 Aug 22.

PMID:
26306677
14.

Radiochromic film-based quality assurance for CT-based high-dose-rate brachytherapy.

Asgharizadeh S, Bekerat H, Syme A, Aldelaijan S, DeBlois F, Vuong T, Evans M, Seuntjens J, Devic S.

Brachytherapy. 2015 Jul-Aug;14(4):578-85. doi: 10.1016/j.brachy.2015.02.192. Epub 2015 Apr 9.

PMID:
25865477
15.

Longitudinal evaluation of the metabolic response of a tumor xenograft model to single fraction radiation therapy using magnetic resonance spectroscopy.

Tessier AG, Yahya A, Larocque MP, Fallone BG, Syme A.

Phys Med Biol. 2014 Sep 7;59(17):5061-72. doi: 10.1088/0031-9155/59/17/5061. Epub 2014 Aug 13.

PMID:
25119471
16.

Design, synthesis and biological evaluation of peptide derivatives of L-dopa as anti-parkinsonian agents.

Zhou T, Hider RC, Jenner P, Campbell B, Hobbs CJ, Rose S, Jairaj M, Tayarani-Binazir KA, Syme A.

Bioorg Med Chem Lett. 2013 Oct 1;23(19):5279-82. doi: 10.1016/j.bmcl.2013.08.007. Epub 2013 Aug 11.

PMID:
23973169
17.

A pan-Canadian practice guideline and algorithm: screening, assessment, and supportive care of adults with cancer-related fatigue.

Howell D, Keller-Olaman S, Oliver TK, Hack TF, Broadfield L, Biggs K, Chung J, Gravelle D, Green E, Hamel M, Harth T, Johnston P, McLeod D, Swinton N, Syme A, Olson K.

Curr Oncol. 2013 Jun;20(3):e233-46. doi: 10.3747/co.20.1302.

18.

Self-reported dietary intake of youth with recent onset of type 2 diabetes: results from the TODAY study.

Delahanty L, Kriska A, Edelstein S, Amodei N, Chadwick J, Copeland K, Galvin B, El Ghormli L, Haymond M, Kelsey MM, Lassiter C, Milaszewski K, Syme A, Mayer-Davis E.

J Acad Nutr Diet. 2013 Mar;113(3):431-9. doi: 10.1016/j.jand.2012.11.015.

19.

Sedentary behavior and physical activity in youth with recent onset of type 2 diabetes.

Kriska A, Delahanty L, Edelstein S, Amodei N, Chadwick J, Copeland K, Galvin B, El ghormli L, Haymond M, Kelsey M, Lassiter C, Mayer-Davis E, Milaszewski K, Syme A.

Pediatrics. 2013 Mar;131(3):e850-6. doi: 10.1542/peds.2012-0620. Epub 2013 Feb 11.

20.

Managing symptoms during cancer treatments: evaluating the implementation of evidence-informed remote support protocols.

Stacey D, Bakker D, Ballantyne B, Chapman K, Cumminger J, Green E, Harrison M, Howell D, Kuziemsky C, MacKenzie T, Sabo B, Skrutkowski M, Syme A, Whynot A.

Implement Sci. 2012 Nov 19;7:110. doi: 10.1186/1748-5908-7-110.

21.

Poster - Thur Eve - 49: Application of plastic scintillating detectors to orthovoltage x-ray measurements.

Nasonkin S, Syme A.

Med Phys. 2012 Jul;39(7Part3):4634. doi: 10.1118/1.4740157.

PMID:
28516697
22.

Sci-Fri PM: Delivery - 09: Response of a tumor xenograft model to radiation therapy using magnetic resonance spectroscopy.

Tessier AG, Yahya A, Larocque M, Fallone BG, Syme A.

Med Phys. 2012 Jul;39(7Part4):4644. doi: 10.1118/1.4740204.

PMID:
28516635
23.

Sequestrate species of Agaricus and Macrolepiota from Australia: new species and combinations and their position in a calibrated phylogeny.

Lebel T, Syme A.

Mycologia. 2012 Mar-Apr;104(2):496-520. doi: 10.3852/11-092. Epub 2011 Nov 8.

PMID:
22067305
24.
25.

Feeding ecology of King George whiting Sillaginodes punctatus (Perciformes) recruits in seagrass and unvegetated habitats. Does diet reflect habitat utilization?

Jenkins GP, Syme A, Macreadie PI.

J Fish Biol. 2011 May;78(5):1561-73. doi: 10.1111/j.1095-8649.2011.02962.x. Epub 2011 Apr 11.

PMID:
21539559
26.

Tumour xenograft detection through quantitative analysis of the metabolic profile of urine in mice.

Moroz J, Turner J, Slupsky C, Fallone G, Syme A.

Phys Med Biol. 2011 Feb 7;56(3):535-56. doi: 10.1088/0031-9155/56/3/002. Epub 2011 Jan 6.

PMID:
21212470
27.

Consensus recommendations for the management of constipation in patients with advanced, progressive illness.

Librach SL, Bouvette M, De Angelis C, Farley J, Oneschuk D, Pereira JL, Syme A; Canadian Consensus Development Group for Constipation in Patients with Advanced Progressive Illness.

J Pain Symptom Manage. 2010 Nov;40(5):761-73. doi: 10.1016/j.jpainsymman.2010.03.026.

PMID:
21075273
28.

ADC response to radiation therapy correlates with induced changes in radiosensitivity.

Larocque MP, Syme A, Allalunis-Turner J, Fallone BG.

Med Phys. 2010 Jul;37(7):3855-61.

PMID:
20831093
29.

Design, synthesis and biological evaluation of L-dopa amide derivatives as potential prodrugs for the treatment of Parkinson's disease.

Zhou T, Hider RC, Jenner P, Campbell B, Hobbs CJ, Rose S, Jairaj M, Tayarani-Binazir KA, Syme A.

Eur J Med Chem. 2010 Sep;45(9):4035-42. doi: 10.1016/j.ejmech.2010.05.062. Epub 2010 Jun 2.

PMID:
20646792
30.

Gene duplication and the origins of morphological complexity in pancrustacean eyes, a genomic approach.

Rivera AS, Pankey MS, Plachetzki DC, Villacorta C, Syme AE, Serb JM, Omilian AR, Oakley TH.

BMC Evol Biol. 2010 Apr 30;10:123. doi: 10.1186/1471-2148-10-123.

31.

Monitoring T2 and ADC at 9.4 T following fractionated external beam radiation therapy in a mouse model.

Larocque MP, Syme A, Yahya A, Wachowicz K, Allalunis-Turner J, Fallone BG.

Phys Med Biol. 2010 Mar 7;55(5):1381-93. doi: 10.1088/0031-9155/55/5/008. Epub 2010 Feb 11.

PMID:
20150684
32.

A treatment planning study comparing helical tomotherapy with intensity-modulated radiotherapy for the treatment of anal cancer.

Joseph KJ, Syme A, Small C, Warkentin H, Quon H, Ghosh S, Field C, Pervez N, Tankel K, Patel S, Usmani N, Severin D, Nijjar T, Fallone G, Pedersen J.

Radiother Oncol. 2010 Jan;94(1):60-6. doi: 10.1016/j.radonc.2009.10.003. Epub 2009 Nov 4.

PMID:
19896229
33.

Relative biological damage and electron fluence in and out of a 6 MV photon field.

Syme A, Kirkby C, Mirzayans R, MacKenzie M, Field C, Fallone BG.

Phys Med Biol. 2009 Nov 7;54(21):6623-33. doi: 10.1088/0031-9155/54/21/012. Epub 2009 Oct 14.

PMID:
19826205
34.

An interdisciplinary team communication framework and its application to healthcare 'e-teams' systems design.

Kuziemsky CE, Borycki EM, Purkis ME, Black F, Boyle M, Cloutier-Fisher D, Fox LA, MacKenzie P, Syme A, Tschanz C, Wainwright W, Wong H; Interprofessional Practices Team.

BMC Med Inform Decis Mak. 2009 Sep 15;9:43. doi: 10.1186/1472-6947-9-43.

35.

Temporal and dose dependence of T2 and ADC at 9.4 T in a mouse model following single fraction radiation therapy.

Larocque MP, Syme A, Yahya A, Wachowicz K, Allalunis-Turner J, Fallone BG.

Med Phys. 2009 Jul;36(7):2948-54.

PMID:
19673193
36.
37.

Sci-Sat AM(1): Imaging-01: Tumour and normal tissue T2 and ADC distributions for a mouse model at 9.4T.

Larocque M, Syme A, Fallone BG.

Med Phys. 2008 Jul;35(7Part3):3414. doi: 10.1118/1.2965985.

PMID:
28512910
38.
39.

A Monte Carlo study of the variation of electron fluence in water from a 6 MV photon beam outside of the field.

Kirkby C, Field C, MacKenzie M, Syme A, Fallone BG.

Phys Med Biol. 2007 Jun 21;52(12):3563-78. Epub 2007 May 22.

PMID:
17664560
40.

Development and reliability testing of the Victoria Bowel Performance Scale (BPS).

Downing GM, Kuziemsky C, Lesperance M, Lau F, Syme A.

J Pain Symptom Manage. 2007 Nov;34(5):513-22. Epub 2007 Jul 30.

PMID:
17664054
41.

Peak systolic blood pressure on a graded maximal exercise test and the blood pressure response to an acute bout of submaximal exercise.

Syme AN, Blanchard BE, Guidry MA, Taylor AW, Vanheest JL, Hasson S, Thompson PD, Pescatello LS.

Am J Cardiol. 2006 Oct 1;98(7):938-43. Epub 2006 Aug 8.

PMID:
16996879
42.

3D interfractional patient position verification using 2D-3D registration of orthogonal images.

Jans HS, Syme AM, Rathee S, Fallone BG.

Med Phys. 2006 May;33(5):1420-39.

PMID:
16752578
43.

Patient specific treatment verifications for helical tomotherapy treatment plans.

Thomas SD, Mackenzie M, Field GC, Syme AM, Fallone BG.

Med Phys. 2005 Dec;32(12):3793-800.

PMID:
16475779
44.

Preliminary results of nanopharmaceuticals used in the radioimmunotherapy of ovarian cancer.

McQuarrie S, Mercer J, Syme A, Suresh M, Miller G.

J Pharm Pharm Sci. 2005 Feb 10;7(4):29-34.

45.

Not just any old standards ... 2002 Canadian Hospice Palliative Care Association standards.

West PJ, Ferris F, Balfour H, Bowen K, Farley J, Hardwick M, Lamontagne C, Lundy M, Syme A.

Can Oncol Nurs J. 2004 Spring;14(2):112-6. Review. English, French. No abstract available.

PMID:
15230031
46.

Monte Carlo investigation of single cell beta dosimetry for intraperitoneal radionuclide therapy.

Syme AM, Kirkby C, Riauka TA, Fallone BG, McQuarrie SA.

Phys Med Biol. 2004 May 21;49(10):1959-72.

PMID:
15214535
47.

Beta dose-rate distributions in microscopic spherical tumors for intraperitoneal radioimmunotherapy.

Syme A, McQuarrie S, Fallone BG.

Int J Radiat Oncol Biol Phys. 2003 Aug 1;56(5):1495-506.

PMID:
12873695
48.

Dosimetric model for intraperitoneal targeted liposomal radioimmunotherapy of ovarian cancer micrometastases.

Syme AM, McQuarrie SA, Middleton JW, Fallone BG.

Phys Med Biol. 2003 May 21;48(10):1305-20.

PMID:
12812448
49.

A model to guide patient and family care: based on nationally accepted principles and norms of practice.

Ferris FD, Balfour HM, Bowen K, Farley J, Hardwick M, Lamontagne C, Lundy M, Syme A, West PJ.

J Pain Symptom Manage. 2002 Aug;24(2):106-23. No abstract available.

PMID:
12231127
50.

CANO Pain Education Initiative Report--Victoria Conference, October 2000.

Crooks D, Struthers C, Syme A, Stotts M, Budz D, Guebert N, Hershon L.

Can Oncol Nurs J. 2001 Spring;11(2):86-9. No abstract available.

PMID:
11894489

Supplemental Content

Support Center